Lunai Bioworks Inc.LNAIEarnings & Financial Report
Nasdaq
NextFeb 27, 2026
LNAI Q2 2024 Key Financial Metrics
Revenue
$15.9K
Gross Profit
N/A
Operating Profit
$-4.3M
Net Profit
$-4.5M
Gross Margin
N/A
Operating Margin
-26791.8%
Net Margin
-28417.1%
YoY Growth
429.5%
EPS
$-0.07
Financial Flow
Lunai Bioworks Inc. Q2 2024 Financial Summary
Lunai Bioworks Inc. reported revenue of $15.9K for Q2 2024, with a net profit of $-4.5M (-28417.1% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $15.9K |
|---|---|
| Net Profit | $-4.5M |
| Gross Margin | N/A |
| Operating Margin | -26791.8% |
| Report Period | Q2 2024 |
Lunai Bioworks Inc. Annual Revenue by Year
Lunai Bioworks Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $-126.6K).
| Year | Annual Revenue |
|---|---|
| 2023 | $-126.6K |
Income Statement
| Q3 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | $7291 | $5623 | $3010 | $-142571 | $7318 | $8375 | $15938 |
| YoY Growth | 107.6% | N/A | N/A | -2055.4% | N/A | 48.9% | 429.5% |
Balance Sheet
| Q3 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|
| Assets | $180.1M | $83.1M | $80.3M | $78.7M | $58.3M | $57.6M | $58.0M |
| Liabilities | $18.9M | $12.7M | $13.4M | $12.6M | $11.8M | $10.8M | $14.4M |
| Equity | $161.2M | $70.3M | $66.9M | $66.1M | $46.5M | $46.7M | $43.6M |
Cash Flow
| Q3 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-2.8M | $-2.8M | $-3.4M | $-3.3M | $-2.3M | $-2.8M | $-3.1M |